Back

Clinical features of drug-induced long QT syndrome in a large prospective cohort

29 August 2022 (17:15 - 17:45)
Organised by:
Congress Presentation Part of: Pharmacological and metabolic impact on ventricular arrhythmias Ion Channel Disorders ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Associate Professor Jose M Guerra

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

3 More presentations in this session

Presentation thumbnail
Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs
Professor G. Frommeyer (Munster, DE)
Abstract Slides
Presentation thumbnail
Amiodarone and ventricular fibrillation amplitude of spectral area in patients with out-of-hospital cardiac arrest. Is there an effect?
Doctor F. Gentile (Pavia, IT)
Abstract Slides
Presentation thumbnail
Bariatric surgery reverses ventricular repolarisation heterogeneity in obesity: mechanistic insights into fat-related arrhythmic risk
Ms N. Herath (GB)
Abstract Slides

Access the full session

Session thumbnail
Pharmacological and metabolic impact on ventricular arrhythmias

The Event

Event poster

ESC Congress 2022

29 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Presentation
QT prolongation following premature ventricular contractions: a potential marker of concealed long QT syndrome
14 April 2026
thumbnail
Webinar
Current role of cardiovascular pharmacotherapy for arrhythmia management
9 December 2021
thumbnail
Congress Presentation
Predictive variables of persistence and recurrence in drug-induced atrioventricular block: a multicenter study
4 March 2019
thumbnail
Congress Presentation
Genetic characterization of drug-induced long QT syndrome in a large prospective cohort
7 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources